Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme
Antoni Torres, Michele Wible, Margaret Tawadrous, Paurus Irani, Gregory G. Stone, Alvaro Quintana, Dmitri Debabov, Margaret Burroughs, Patricia A. Bradford, Marin Kollef
Dive into the research topics of 'Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme'. Together they form a unique fingerprint.